About 15–25% of BC cases display amplification and/or overexpression of Epidermal Growth Factor Receptor Type-2 (HER2) [3,4], an oncoprotein that interacts with cell-proliferation pathways to grant protection against apoptosis. The gene discussed is ERBB2; the disease is breast cancer.